메틸수은 노출이 흰쥐의 태반 효율과 태아 성장에 미치는 영향
Effects of Methyl Mercury Exposure on Placental Efficiency and Fetal Growth Retardation in Rats
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: Some animal studies have reported that methyl mercury causes developmental toxicities such as placental and fetal weight loss, but the mechanism is still unclear. This study aimed to investigate the developmental toxicities of methyl mercury, focusing on placental endocrine function and fetal growth retardation in rats. Methods: Positively same-time-mated female Sprague-Dawley rats were purchased on gestational day (GD) eight and treated with 0, 5, 10 and 20 ppm of methyl mercury (n=5) dissolved in tap water from GD eight through 19. During treatment, the drinking water (methyl mercury) intake and body weight of each pregnant rat was measured daily. On day 19, caesarean sections were performed and blood samples were collected. Developmental data such as placental and fetal weights, fetus numbers, and placental efficiency (fetal weight/ placental weight) were also collected. Placental prolactin-growth hormone (PRL-GH) family, such as placental lactogen (PL) -Iv, II, and prolactin-like protein (PLP) -B, levels in serum were analyzed by ELISA. Also, placental tissues were assigned to histochemistry. Results: The mean cumulative methyl mercury exposure for the 5, 10, and 20 ppm groups were 2.37, 4.63, and 9.66 mg, respectively. The mean daily exposure of the 5, 10, and 20 ppm groups were 0.24, 0.47, and 0.97 mg, respectively. Maternal body weight increased in accordance with GD. There was no significant difference in weight gain among the experimental groups. Histopathologic changes were not observed in placental tissues among the experimental groups. However, mean placental and fetal weights were lower in the 10 and 20 ppm exposed groups compared to the control. Placental efficiency was also lower in the 10 and 20 ppm exposed groups compared to the control. Serum PL-Iv and II levels were lower in the 10 and 20 ppm exposed groups than the control, in accordance with the changing pattern of placental and fetal weights and placental efficiency. Conclusion: The inhibitory effects of methyl mercury on the serum levels of placental PRL-GH family such as PL-Iv and II may be secondary leads to the reduction of placental efficiency and fetal growth retardation in rats.
Abstract
Objectives: Some animal studies have reported that methyl mercury causes developmental toxicities such as placental and fetal weight loss, but the mechanism is still unclear. This study aimed to investigate the developmental toxicities of methyl mercury, focusing on placental endocrine function and fetal growth retardation in rats. Methods: Positively same-time-mated female Sprague-Dawley rats were purchased on gestational day (GD) eight and treated with 0, 5, 10 and 20 ppm of methyl mercury (n=5) dissolved in tap water from GD eight through 19. During treatment, the drinking water (methyl mercury) intake and body weight of each pregnant rat was measured daily. On day 19, caesarean sections were performed and blood samples were collected. Developmental data such as placental and fetal weights, fetus numbers, and placental efficiency (fetal weight/ placental weight) were also collected. Placental prolactin-growth hormone (PRL-GH) family, such as placental lactogen (PL) -Iv, II, and prolactin-like protein (PLP) -B, levels in serum were analyzed by ELISA. Also, placental tissues were assigned to histochemistry. Results: The mean cumulative methyl mercury exposure for the 5, 10, and 20 ppm groups were 2.37, 4.63, and 9.66 mg, respectively. The mean daily exposure of the 5, 10, and 20 ppm groups were 0.24, 0.47, and 0.97 mg, respectively. Maternal body weight increased in accordance with GD. There was no significant difference in weight gain among the experimental groups. Histopathologic changes were not observed in placental tissues among the experimental groups. However, mean placental and fetal weights were lower in the 10 and 20 ppm exposed groups compared to the control. Placental efficiency was also lower in the 10 and 20 ppm exposed groups compared to the control. Serum PL-Iv and II levels were lower in the 10 and 20 ppm exposed groups than the control, in accordance with the changing pattern of placental and fetal weights and placental efficiency. Conclusion: The inhibitory effects of methyl mercury on the serum levels of placental PRL-GH family such as PL-Iv and II may be secondary leads to the reduction of placental efficiency and fetal growth retardation in rats.
참고문헌 (32)
- Stacey NH, "Comparison of the effects of metals on cellular injury and lipid peroxidation in isolated rat hepatocytes", J Toxicol Environ Health, 7, pp.139~147 (1980)
- Roman HA, "Evaluation of the cardiovascular effects of methylmercury exposures : current evidence supports development of a doseresponse function for regulatory benefits analysis", Environ Health Perspect, 119, pp.607~614 (2011)
- Annual report of the National Environmental Health Survey (KoNEHS), "NIER (National Institute of Environmental Research)", ~ (2018)
- Annual report of the National Environmental Health Survey (KoNEHS), "NIER (National Institute of Environmental Research)", ~ (2012)
- Rice DC, "Methods and rationale for derivation of a reference dose for methylmercury by the U.S. EPA", Risk analysis : an official publication of the Society for Risk Analysis, 23, pp.107~115 (2003)
- Yanga Z, "Developmental exposure to mercury chloride impairs social behavior in male offspring dependent on genetic background and maternal autoimmune environment", Toxicology and Applied Pharmacology, 370, pp.1~13 (2019)
- Kabuto M, "Acute endocrine effects of a single administration of methylmercury chloride(MMC)in rats", Endocrinol Jpn, 33, pp.683~690 (1986)
- Vahter M, "Longitudinal study of methylmercury and inorganic mercury in blood and urine of pregnant and lactating women, as well as in 71 umbilical cord", Environmental Research, 84, pp.186~194 (2000)
- Curle R, "In vivo evaluation of teratogenesis and cytogenetic changes following methylmercuric chloride treatment", The Anatomical Record, 219, pp.289~295 (1987)
- Weng Z, "Zinc Protection in Fetal Rats for Maternal Mercury Exposure-Induced Growth Retardation Is Probably Associated With S100B Expression", J Obstet Gynaecol Res, 43, pp.73~77 (2017)
- 김대선, "수은 고노출 지역 초등학생의 수은노출관련 건강영향 연구", 한국환경보건학회지, 41(4), pp.268~276 (2015), 한국환경보건학회
- Kim BM, "Mercury levels in maternal and cord blood and attained weight through the 24 months of life", Sci Total Environ, 410, pp.26~33 (2011)
- Robertson MC, "Expression, purification, and characterization of recombinant rat placental lactogen-I : a comparison with the native hormone", Endocrinology, 134, pp.393~400 (1994)
- Dai G, "Prolactin-like protein-C variant : complementary deoxyribonucleic acid, unique six exon gene structure, and trophoblast cell-specific expression", Endocrinology, 137, pp.5009~5019 (1996)
- Forsyth I, "Prolactin, growth hormones, and placental lactogens : an historical perspective", J Mammary Gland Biol Neoplasia, 2, pp.3~6 (1997)
- Lee CK, "Effects of perfluorooctane sulfuric acid on placental PRL-family hormone production and fetal growth retardation in mice", Molecular and Cellular Endocrinology, 401, pp.165~172 (2015)
- Li J, "Human placental lactogen mRNA in maternal plasma play a role in prenatal diagnosis of abnormally invasive placenta: yes or no?", Gynecol Endocrinol, 35, pp.631~634 (2019)
- Lee JH, "Methylmercuric chloride(MMC)and reduction of the fetal ossification in fisher-334 rats furing organogenesis", J Environ Health Sci, 27, pp.73~87 (2001)
- Oliveira CS, "Inorganic Mercury Exposure in Drinking Water Alters Essential Metal Homeostasis in Pregnant Rats Without Altering Rat Pup Behavior", Reprod Toxicol, 65, pp.18~23 (2016)
- Simmons DG, "Spatial and temporal expression of the 23murine Prolactin", Placental Lactogen-related genes is not associated with their position in the locus, 2008, pp.9, 352~373
- Thordarson G, "Interaction of mouse placental lactogens and androgens in regulating progesterone release in cultured mouse luteal cells", Endocrinology, 138, pp.3236~3241 (1997)
- Telleria CM, "Differential expression of the estrogen receptors alpha and beta in the rat corpus luteum of pregnancy : regulation by prolactin and placental lactogens", Endocrinology, 139, pp.2432~2442 (1998)
- Conliffe PR, "Cloning of a novel rat placental prolactin-like protein C-related cDNA", Mol Reprod Dev, 41, pp.167~176 (1995)
- Cohick CB, "Prolactin-like protein-B : heterologous expression and characterization of placental and decidual species", J Endocrinol, 152, pp.291~302 (1997)
- Rasmussen CA, "Dual expression of prolactin-related protein in decidua and trophoblast tissues during pregnancy in rats", Biol Reprod, 56, pp.647~654 (1997)
- Lee CK, "Effects of cadmium on the expression of placental lactogens and Pit-1 genes in the rat placental trophoblast cells", Molecular and Cellular Endocrinology, 298, pp.11~18 (2009)
- Bodner M, "A pituitary-specific transacting factor can stimulate transcription from the growth hormone promoter in extracts of nonexpressing cells", Cell, 50, pp.267~275 (1987)
- Bamberger AM, "Expression of pit-1 messenger ribonucleic acid and protein in the human placenta", J Clin Endocrinol Metab, 80, pp.2021~2026 (1995)
- Lee CK, "Effects of dopamine and estrogen on the regulation of Pit-1 alpha, Pit-2 beta and PL-II gene expression in the rat placenta", Mol Cells, 8, pp.205~211 (1998)
- Roby KF, "Trophoblast cell differentiation and organization : role of fetal and ovarian signals", Placenta, 14, pp.529~545 (1993)
- Cronier L, "Oestradiol stimulates morphological and functional differentiation of human villous cytotrophoblast", Placenta, 20, pp.669~676 (1999)
- Zhanag X, "Experimental study on the estrogen-like effect of mercuric chloride", Biometals, 21, pp.145~150 (2008)